Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Acta Haematologica
|
July 24, 2019
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)
Sanford Kempin, Zhuoxin Sun, Neil E Kay, et al.
The Oncologist
|
February 17, 2021
A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study
John M Varlotto, Zhuoxin Sun, Bonnie Ky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
The New England Journal of Medicine
|
September 25, 2009
Anthracycline dose intensification in acute myeloid leukemia
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Breast Cancer Research : BCR
|
November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Nature Neuroscience
|
January 18, 2006
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
Michelle Day, Zhongfeng Wang, Jun Ding, et al.
Breast Cancer Research and Treatment
|
February 4, 2014
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
Andrea Decensi, Zhuoxin Sun, Aliana Guerrieri-Gonzaga, et al.
British Journal of Haematology
|
November 19, 2015
Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
Thomas Prebet, Zhuoxin Sun, Rhett P Ketterling, et al.
Breast Cancer Research and Treatment
|
November 7, 2020
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial
Manuela Rabaglio, Zhuoxin Sun, Rudolf Maibach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905
Thomas Prebet, Zhuoxin Sun, Maria E Figueroa, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Acta Haematologica
|
July 24, 2019
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)
Sanford Kempin, Zhuoxin Sun, Neil E Kay, et al.
The Oncologist
|
February 17, 2021
A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study
John M Varlotto, Zhuoxin Sun, Bonnie Ky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
The New England Journal of Medicine
|
September 25, 2009
Anthracycline dose intensification in acute myeloid leukemia
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Breast Cancer Research : BCR
|
November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Nature Neuroscience
|
January 18, 2006
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
Michelle Day, Zhongfeng Wang, Jun Ding, et al.
Breast Cancer Research and Treatment
|
February 4, 2014
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
Andrea Decensi, Zhuoxin Sun, Aliana Guerrieri-Gonzaga, et al.
British Journal of Haematology
|
November 19, 2015
Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
Thomas Prebet, Zhuoxin Sun, Rhett P Ketterling, et al.
Breast Cancer Research and Treatment
|
November 7, 2020
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial
Manuela Rabaglio, Zhuoxin Sun, Rudolf Maibach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905
Thomas Prebet, Zhuoxin Sun, Maria E Figueroa, et al.
Page
of 8